H.C. Wainwright initiated coverage on NewAmsterdam Pharma with a new price target
$NAMS
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright initiated coverage of NewAmsterdam Pharma with a rating of Buy and set a new price target of $48.00